Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
LifeMD, Inc.

LifeMD, Inc. (LFMD) Stock Overview

Explore LifeMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LFMD●NASDAQ
HealthcareMedical - Pharmaceuticals
$3.62
$0.06(1.69%)
U.S. Market opens in 11h 44m

LifeMD, Inc. (LFMD)

Meyka AI Score

Z

Key Financials

Market Cap175.1M
P/E Ratio-7.11
EPS (TTM)$-0.50
ROE-1.79%
Fundamental Analysis

AI Price Forecasts

1 Month$2.91
3 Months$0.00
1 Year Target$3.17

LFMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of LifeMD, Inc. (NASDAQ: LFMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, LifeMD, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LFMD on the NASDAQ shows an RSI of 41.09, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.17 for the NASDAQ listing.

Key metrics behind LifeMD, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.11 and a market capitalization of 175.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LFMD on the NASDAQ.

Price Performance (NASDAQ: LFMD)

1-Day Change
1.69%
5-Day Change
-7.18%
1-Month Change
-21.98%
3-Month Change
-24.27%
6-Month Change
18.69%
Year-to-Date (YTD) Change
6.16%
1-Year Change
-46.13%
3-Year Change
-17.35%
5-Year Change
-61.16%
All-Time (Max) Change
1710.00%

Contact Information

https://www.lifemd.com
866 351 5907
236 Fifth Avenue, New York City, NY, 10001

Company Facts

3,890 Employees
IPO DateJan 29, 2008
CountryUS
Actively Trading

Frequently Asked Questions